Aquestive Therapeutics, Inc. Expense Breakdown
No Expense Breakdown for AQST on this site yet.
- 2026-06-30: Reportable $4.02M.
- 2025-06-30: Reportable $4.56M.
Source checked: the stored Expense Breakdown page for AQST.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $4.02M |
|---|
| 2025-06-30 | $4.56M |
|---|
Costs and Expenses: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $22.04M |
|---|
| 2025-06-30 | $21.37M |
|---|
General And Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $11.89M |
|---|
| 2025-06-30 | $9.19M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $3.96M |
|---|
| 2025-06-30 | $4.11M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Reportable |
|---|
| 2026-06-30 | $14.06M |
|---|
| 2025-06-30 | $12.71M |
|---|